Lucentis Dosage

Generic name: ranibizumab (ophthalmic)
Drug class: Anti-angiogenic ophthalmic agents

Medically reviewed by  A Ras MD.

Recommended Adult Dosing

Dosage forms:  INJ (pre-filled syringe): 0.3 mg per 0.05 mL, 0.5 mg per 0.05 mL; INJ (vial): 0.3 mg per 0.05 mL, 0.5 mg per 0.05 mL

Age-related macular degeneration, neovascular

[0.5 mg intravitreal injection qmo]

Info: may decr. to 0.5 mg q2mo after 3 doses or 0.5 mg q3mo after 4 doses; less frequent dosing not as effective as qmo

Macular edema, retinal vein occlusion-assoc.

[0.5 mg intravitreal injection qmo]

Diabetic macular edema

[0.3 mg intravitreal injection qmo]

Diabetic retinopathy

[0.3 mg intravitreal injection qmo]

Myopic choroidal neovascularization

[0.5 mg intravitreal injection qmo for up to 3mo]

Info: may repeat tx based on response

Renal dosing

[no adjustment]

renal impairment: no adjustment

HD/PD: no adjustment; no supplement

Hepatic dosing

[not defined]

SRC: NLM .